Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway.

Area of Science:

• Molecular Biology
• Cell Signaling
• Oncogenesis

Background:

• The Src oncogene is known to upregulate matrix metalloproteinase-2 (MMP-2) expression.
• Understanding the precise molecular mechanisms behind Src-induced MMP-2 expression is crucial for cancer research.

Purpose of the Study:

• To elucidate the signaling pathway through which the Src oncogene induces MMP-2 expression.
• To identify the key regulatory elements and transcription factors involved in Src-mediated MMP-2 transcriptional activation.

Main Methods:

• Utilized murine fibroblast cell line C3H10T1/2 and its v-Src transfectant IV5.
• Employed RT-PCR, promoter activity assays, deletion/mutation analysis, and electrophoresis mobility shift assays.
• Investigated the role of signaling pathways using specific inhibitors (PD98059, SP600125, SB203580, wortmannin) and dominant-negative mutants.

Main Results:

• Src stimulation of MMP-2 occurs via transcriptional activation, confirmed by mRNA expression and promoter activity assays.
• The Sp1 binding site (-91/-84) in the MMP-2 promoter is essential for Src-induced activation.
• The extracellular signal-regulated kinase (ERK) pathway, but not JNK, p38, or PI3K, mediates Src's effect on MMP-2.
• Src activation enhances Sp1 binding to its consensus site, leading to increased MMP-2 gene expression.

Conclusions:

• Src oncogene induces MMP-2 expression through transcriptional activation.
• The ERK/Sp1 signaling pathway plays a critical role in mediating Src-induced MMP-2 expression.